drugset / Trial / NCT06232252
A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy Men
RandomizedParallel-groupDouble-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics of BI 765423 in healthy male subjects.
Timeline
- Start
- 2024-05-06
- Primary completion
- 2025-04-25
- Completion
- 2025-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 765423 | Unknown | — | Intravenous |
Indications
No indication recorded.